GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Price-to-Owner-Earnings

China National Accord Medicines (SZSE:000028) Price-to-Owner-Earnings : 15.58 (As of May. 26, 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Price-to-Owner-Earnings?

As of today (2024-05-26), China National Accord Medicines's share price is ¥38.33. China National Accord Medicines's Owner Earnings per Share (TTM) ended in Mar. 2024 was ¥2.46. It's Price-to-Owner-Earnings for today is 15.58.


The historical rank and industry rank for China National Accord Medicines's Price-to-Owner-Earnings or its related term are showing as below:

SZSE:000028' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.34   Med: 21.56   Max: 66.69
Current: 15.56

During the past 13 years, the highest Price-to-Owner-Earnings of China National Accord Medicines was 66.69. The lowest was 11.34. And the median was 21.56.


SZSE:000028's Price-to-Owner-Earnings is ranked worse than
57.45% of 47 companies
in the Medical Distribution industry
Industry Median: 13.96 vs SZSE:000028: 15.56

As of today (2024-05-26), China National Accord Medicines's share price is ¥38.33. China National Accord Medicines's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.92. Therefore, China National Accord Medicines's PE Ratio for today is 13.13.

As of today (2024-05-26), China National Accord Medicines's share price is ¥38.33. China National Accord Medicines's EPS without NRI for the trailing twelve months (TTM) ended in was ¥3.09. Therefore, China National Accord Medicines's PE Ratio without NRI for today is 12.40.

During the past 13 years, China National Accord Medicines's highest PE Ratio without NRI was 45.97. The lowest was 7.85. And the median was 16.57.


China National Accord Medicines Price-to-Owner-Earnings Historical Data

The historical data trend for China National Accord Medicines's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Price-to-Owner-Earnings Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.85 16.83 14.37 11.39 12.09

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.12 17.53 12.80 12.09 12.47

Competitive Comparison of China National Accord Medicines's Price-to-Owner-Earnings

For the Medical Distribution subindustry, China National Accord Medicines's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Price-to-Owner-Earnings falls into.



China National Accord Medicines Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

China National Accord Medicines's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=38.33/2.46
=15.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines  (SZSE:000028) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


China National Accord Medicines Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines